高カリウム血症治療薬の世界市場（2022年～2026年）

世界の高カリウム血症治療薬の市場規模は、2022年から2026年の予測期間中に18.65％のCAGRで推移し、8億317万米ドルの成長が見込まれています。

同市場の成長を後押しする主な要因には、慢性疾患の症例の増加、様々な治療薬の使用の増加、高カリウム血症の有病率の上昇などが挙げられます。

当レポートでは、世界の高カリウム血症治療薬市場を調査しており、市場の概要、市場規模や予測、動向、成長要因および課題、顧客情勢、タイプ・地域別の分析、さらにベンダー情勢およびベンダー分析などを提供しています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場のエコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模：2021年
• 市場の見通し：2021年から2026年の予測

第4章 ファイブフォース分析

• ファイブフォースサマリー
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• ライバルの脅威
• 市況

第5章 タイプ別の市場内訳

• マーケット・セグメント
• タイプ別の比較
• 慢性高カリウム血症：市場規模と予測（2021年～2026年）
• 急性高カリウム血症：市場規模と予測（2021年～2026年）
• タイプ別の市場機会

第6章 顧客情勢

• 顧客情勢の概要

第7章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測（2021年～2026年）
• 欧州：市場規模と予測（2021年～2026年）
• アジア：市場規模と予測（2021年～2026年）
• その他の地域：市場規模と予測（2021年～2026年）
• 米国：市場規模と予測（2021年～2026年）
• ドイツ：市場規模と予測（2021年～2026年）
• カナダ：市場規模と予測（2021年～2026年）
• フランス：市場規模と予測（2021年～2026年）
• 英国：市場規模と予測（2021年～2026年）
• 地域情勢別の市場機会

第8章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 成長要因と課題の影響
• 市場動向

第9章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱情勢
• 業界のリスク

第10章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AdvaCare International
• Ardelyx Inc.
• AstraZeneca Plc
• CytoSorbents Corp.
• KVK Tech Inc.
• Sanofi SA
• Steadfast MediShield Pvt. Ltd.
• Vifor Pharma Management Ltd.

第11章 付録

• 調査範囲
• 包含と除外のチェックリスト
• 米ドルの為替レート
• 調査手法
• 略語のリスト

Technavio has been monitoring the hyperkalemia drugs market and it is poised to grow by $ 803.17 mn during 2022-2026 progressing at a CAGR of 18.65% during the forecast period. Our report on the hyperkalemia drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by growing cases of chronic diseases, growing use of various therapeutics, and the increasing prevalence of hyperkalemia.

The hyperkalemia drugs market analysis includes the type segment and geographic landscape.

Technavio's hyperkalemia drugs market is segmented as below:

By Type

• Chronic hyperkalemia
• Acute hyperkalemia

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies patient assistance programs as one of the prime reasons driving the hyperkalemia drugs market growth during the next few years. Also, strategic alliances and growing awareness about hyperkalemia will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on hyperkalemia drugs market covers the following areas:

• Hyperkalemia drugs market sizing
• Hyperkalemia drugs market forecast
• Hyperkalemia drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hyperkalemia drugs market vendors that include AdvaCare International, Ardelyx Inc., AstraZeneca Plc, CytoSorbents Corp., KVK Tech Inc., Sanofi SA, Steadfast MediShield Pvt. Ltd., and Vifor Pharma Management Ltd. Also, the hyperkalemia drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments
• Exhibit 24: Chart on Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
• 5.2 Comparison by Type
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type
• 5.3 Chronic hyperkalemia - Market size and forecast 2021-2026
• Exhibit 28: Chart on Chronic hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Chronic hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Chronic hyperkalemia - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Chronic hyperkalemia - Year-over-year growth 2021-2026 (%)
• 5.4 Acute hyperkalemia - Market size and forecast 2021-2026
• Exhibit 32: Chart on Acute hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Acute hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Acute hyperkalemia - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Acute hyperkalemia - Year-over-year growth 2021-2026 (%)
• 5.5 Market opportunity by Type
• Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 Canada - Market size and forecast 2021-2026
• Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.10 France - Market size and forecast 2021-2026
• Exhibit 70: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on France - Year-over-year growth 2021-2026 (%)
• 7.11 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification
• 10.3 AdvaCare International
• Exhibit 85: AdvaCare International - Overview
• Exhibit 86: AdvaCare International - Product / Service
• Exhibit 87: AdvaCare International - Key offerings
• 10.4 Ardelyx Inc.
• Exhibit 88: Ardelyx Inc. - Overview
• Exhibit 89: Ardelyx Inc. - Business segments
• Exhibit 90: Ardelyx Inc. - Key news
• Exhibit 91: Ardelyx Inc. - Key offerings
• Exhibit 92: Ardelyx Inc. - Segment focus
• 10.5 AstraZeneca Plc
• Exhibit 93: AstraZeneca Plc - Overview
• Exhibit 94: AstraZeneca Plc - Product / Service
• Exhibit 95: AstraZeneca Plc - Key news
• Exhibit 96: AstraZeneca Plc - Key offerings
• 10.6 CytoSorbents Corp.
• Exhibit 97: CytoSorbents Corp. - Overview
• Exhibit 98: CytoSorbents Corp. - Business segments
• Exhibit 99: CytoSorbents Corp. - Key news
• Exhibit 100: CytoSorbents Corp. - Key offerings
• Exhibit 101: CytoSorbents Corp. - Segment focus
• 10.7 KVK Tech Inc.
• Exhibit 102: KVK Tech Inc. - Overview
• Exhibit 103: KVK Tech Inc. - Business segments
• Exhibit 104: KVK Tech Inc. - Key offerings
• Exhibit 105: KVK Tech Inc. - Segment focus
• 10.8 Sanofi SA
• Exhibit 106: Sanofi SA - Overview
• Exhibit 107: Sanofi SA - Business segments
• Exhibit 108: Sanofi SA - Key news
• Exhibit 109: Sanofi SA - Key offerings
• Exhibit 110: Sanofi SA - Segment focus
• 10.9 Steadfast MediShield Pvt. Ltd.
• Exhibit 111: Steadfast MediShield Pvt. Ltd. - Overview
• Exhibit 112: Steadfast MediShield Pvt. Ltd. - Business segments
• Exhibit 113: Steadfast MediShield Pvt. Ltd. - Key offerings
• Exhibit 114: Steadfast MediShield Pvt. Ltd. - Segment focus
• 10.10 Vifor Pharma Management Ltd.
• Exhibit 115: Vifor Pharma Management Ltd. - Overview
• Exhibit 116: Vifor Pharma Management Ltd. - Business segments
• Exhibit 117: Vifor Pharma Management Ltd. - Key news
• Exhibit 118: Vifor Pharma Management Ltd. - Key offerings
• Exhibit 119: Vifor Pharma Management Ltd. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 120: Inclusions checklist
• Exhibit 121: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 122: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 123: Research methodology
• Exhibit 124: Validation techniques employed for market sizing
• Exhibit 125: Information sources
• 11.5 List of abbreviations
• Exhibit 126: List of abbreviations

Exhibits

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Type - Market share 2021-2026 (%)
• Exhibits25: Data Table on Type - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Type
• Exhibits27: Data Table on Comparison by Type
• Exhibits28: Chart on Chronic hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Chronic hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Chronic hyperkalemia - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Chronic hyperkalemia - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Acute hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Acute hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Acute hyperkalemia - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Acute hyperkalemia - Year-over-year growth 2021-2026 (%)
• Exhibits36: Market opportunity by Type ($ million)
• Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits40: Chart on Geographic comparison
• Exhibits41: Data Table on Geographic comparison
• Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on France - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits78: Market opportunity By Geographical Landscape ($ million)
• Exhibits79: Impact of drivers and challenges in 2021 and 2026
• Exhibits80: Overview on Criticality of inputs and Factors of differentiation
• Exhibits81: Overview on factors of disruption
• Exhibits82: Impact of key risks on business
• Exhibits83: Vendors covered
• Exhibits84: Matrix on vendor position and classification
• Exhibits85: AdvaCare International - Overview
• Exhibits86: AdvaCare International - Product / Service
• Exhibits87: AdvaCare International - Key offerings
• Exhibits88: Ardelyx Inc. - Overview
• Exhibits89: Ardelyx Inc. - Business segments
• Exhibits90: Ardelyx Inc. - Key news
• Exhibits91: Ardelyx Inc. - Key offerings
• Exhibits92: Ardelyx Inc. - Segment focus
• Exhibits93: AstraZeneca Plc - Overview
• Exhibits94: AstraZeneca Plc - Product / Service
• Exhibits95: AstraZeneca Plc - Key news
• Exhibits96: AstraZeneca Plc - Key offerings
• Exhibits97: CytoSorbents Corp. - Overview
• Exhibits98: CytoSorbents Corp. - Business segments
• Exhibits99: CytoSorbents Corp. - Key news
• Exhibits100: CytoSorbents Corp. - Key offerings
• Exhibits101: CytoSorbents Corp. - Segment focus
• Exhibits102: KVK Tech Inc. - Overview
• Exhibits103: KVK Tech Inc. - Business segments
• Exhibits104: KVK Tech Inc. - Key offerings
• Exhibits105: KVK Tech Inc. - Segment focus
• Exhibits106: Sanofi SA - Overview
• Exhibits107: Sanofi SA - Business segments
• Exhibits108: Sanofi SA - Key news
• Exhibits109: Sanofi SA - Key offerings
• Exhibits110: Sanofi SA - Segment focus
• Exhibits111: Steadfast MediShield Pvt. Ltd. - Overview
• Exhibits112: Steadfast MediShield Pvt. Ltd. - Business segments
• Exhibits113: Steadfast MediShield Pvt. Ltd. - Key offerings
• Exhibits114: Steadfast MediShield Pvt. Ltd. - Segment focus
• Exhibits115: Vifor Pharma Management Ltd. - Overview
• Exhibits116: Vifor Pharma Management Ltd. - Business segments
• Exhibits117: Vifor Pharma Management Ltd. - Key news
• Exhibits118: Vifor Pharma Management Ltd. - Key offerings
• Exhibits119: Vifor Pharma Management Ltd. - Segment focus
• Exhibits120: Inclusions checklist
• Exhibits121: Exclusions checklist
• Exhibits122: Currency conversion rates for US$
• Exhibits123: Research methodology
• Exhibits124: Validation techniques employed for market sizing
• Exhibits125: Information sources
• Exhibits126: List of abbreviations